DE60318391D1 - Bakteriophagen-lysin - Google Patents

Bakteriophagen-lysin

Info

Publication number
DE60318391D1
DE60318391D1 DE60318391T DE60318391T DE60318391D1 DE 60318391 D1 DE60318391 D1 DE 60318391D1 DE 60318391 T DE60318391 T DE 60318391T DE 60318391 T DE60318391 T DE 60318391T DE 60318391 D1 DE60318391 D1 DE 60318391D1
Authority
DE
Germany
Prior art keywords
lysin
nucleotide sequence
bacteriophages
lysine
colonising
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60318391T
Other languages
English (en)
Other versions
DE60318391T2 (de
Inventor
Markus Zimmer
Martin Loessner
Andrew John Morgan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hyglos Invest GmbH
Biomerieux SA
Original Assignee
Profos AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Profos AG filed Critical Profos AG
Publication of DE60318391D1 publication Critical patent/DE60318391D1/de
Application granted granted Critical
Publication of DE60318391T2 publication Critical patent/DE60318391T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60318391T 2002-02-04 2003-01-22 Bakteriophagen-lysin Expired - Lifetime DE60318391T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0202556 2002-02-04
GBGB0202556.7A GB0202556D0 (en) 2002-02-04 2002-02-04 Novel Protein
PCT/IB2003/000559 WO2003066845A2 (en) 2002-02-04 2003-01-22 Bacteriophage lysin

Publications (2)

Publication Number Publication Date
DE60318391D1 true DE60318391D1 (de) 2008-02-14
DE60318391T2 DE60318391T2 (de) 2009-01-02

Family

ID=9930362

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60318391T Expired - Lifetime DE60318391T2 (de) 2002-02-04 2003-01-22 Bakteriophagen-lysin

Country Status (13)

Country Link
US (1) US7371375B2 (de)
EP (1) EP1472344B1 (de)
JP (1) JP4436135B2 (de)
CN (1) CN1813062A (de)
AT (1) ATE382685T1 (de)
AU (1) AU2003205993B2 (de)
CA (1) CA2474145A1 (de)
DE (1) DE60318391T2 (de)
DK (1) DK1472344T3 (de)
ES (1) ES2298495T3 (de)
GB (1) GB0202556D0 (de)
IL (1) IL162917A0 (de)
WO (1) WO2003066845A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006061002A1 (de) 2006-12-22 2008-06-26 Profos Ag Verfahren und Mittel zur Anreicherung, Entfernung und zum Nachweis von gram-positiven Bakterien
US7625739B2 (en) * 2007-08-14 2009-12-01 Intralytix, Inc. Clostridium perfringens bacteriophage and uses thereof
US7625740B2 (en) * 2007-08-17 2009-12-01 Intralytix, Inc. Clostridium perfringens bacteriophage and uses thereof
AU2008328584A1 (en) * 2007-11-26 2009-06-04 Plant Bioscience Limited Novel polypeptides having endolysin activity and uses thereof
US8956628B2 (en) 2007-12-13 2015-02-17 Zoetis Products Llc Bacteriophage preparations and method of use thereof
US9320795B2 (en) * 2007-12-13 2016-04-26 Zoctis Server LLC Bacteriophage preparations and methods of use thereof
EP2143729A1 (de) 2008-07-07 2010-01-13 Hyglos Invest GmbH Neues enzymatisches Aktivenzym gegen Clostridium
US9848760B2 (en) * 2009-06-29 2017-12-26 Gearbox, Llc Devices for continual monitoring and introduction of gastrointestinal microbes
US8962297B2 (en) * 2010-09-01 2015-02-24 The United States Of America, As Represented By The Secretary Of Agriculture Bacteriophage lytic enzymes as alternative antimicrobials
GB201302042D0 (en) * 2013-02-05 2013-03-20 Plant Bioscience Ltd Novel polypeptides having endolysin activity and uses thereof
KR101381798B1 (ko) * 2013-02-27 2014-04-07 씨제이제일제당 (주) 신규 박테리오파지 및 이를 포함하는 항균 조성물
KR101381797B1 (ko) * 2013-02-27 2014-04-07 씨제이제일제당 (주) 신규 박테리오파지 및 이를 포함하는 항균 조성물
DE102013106455A1 (de) 2013-06-20 2014-12-24 Airbus Defence and Space GmbH Verfahren zur Dekontamination von bakteriologischen Verunreinigungen
KR20150018171A (ko) * 2013-08-09 2015-02-23 주식회사 인트론바이오테크놀로지 클로스트리디움 퍼프린젠스 감염을 방지 및 처치하는 방법
KR101649849B1 (ko) * 2014-12-29 2016-08-22 주식회사 인트론바이오테크놀로지 신규한 클로스트리디움 퍼프린젠스 박테리오파지 Ｃｌｏ-ＰＥＰ-1 및 이의 클로스트리디움 퍼프린젠스 증식 억제 용도
CN105062992B (zh) * 2015-07-20 2018-05-11 昆明理工大学 一种细胞内溶素和编码此细胞内溶素的多核苷酸
EP3341013A4 (de) * 2015-09-13 2018-07-18 The Rockefeller University Clostridium difficile-bacteriophagen-lysine für den nachweis und die behandlung von infektionen mit clostridium-difficile-bakterien
EP3372091A1 (de) * 2017-03-07 2018-09-12 Nomad Bioscience GmbH Verfahren zur verringerung der verschmutzung eines objekts mit clostridium
EP3724330A4 (de) * 2017-12-13 2021-11-24 The Rockefeller University Zusammensetzungen und verfahren mit lysin-plycp025 und derivaten davon
GB201901364D0 (en) * 2019-01-31 2019-03-20 Axitan Ltd Endolysins
AU2020268752A1 (en) * 2019-05-08 2021-12-02 Biontech R&D (Austria) Gmbh Novel gardnerella endolysins and uses thereof
CN111226986A (zh) * 2020-01-20 2020-06-05 上海交通大学 含养殖环境噬菌体组合物的喷雾消毒剂、其制备方法和应用
CN111471671B (zh) * 2020-04-16 2022-04-12 中国农业大学 一种具有抑制产气荚膜梭菌活性的蛋白质及其相关生物材料与应用
CN113101305B (zh) * 2021-03-12 2022-06-24 北京艾克赛德生物工程有限公司 发酵蚯蚓粉及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0290295B1 (de) * 1987-05-07 1992-08-05 Microbial Developments Limited Antimikrobische Zubereitungen
GB2255561B (en) * 1991-04-20 1995-06-21 Agricultural & Food Res Lysins from bacteriophages
US6248324B1 (en) * 1997-10-31 2001-06-19 Vincent Fischetti Bacterial phage associated lysing enzymes for treating dermatological infections
US6254866B1 (en) * 1997-10-31 2001-07-03 New Horizons Diagnostics Corporation Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract
DE19837751A1 (de) 1998-08-20 2000-02-24 Siegfried Scherer Markierung, Immobilisierung, Anreicherung, Reinigung und Nachweis von Zellen mittels der Verwendung spezifischer Zellwand-bindender Domänen (CBD) von Zellwand-bindenden Proteinen aus Viren, Bakterien oder eukaryontischen Zellen

Also Published As

Publication number Publication date
DK1472344T3 (da) 2008-05-05
EP1472344A2 (de) 2004-11-03
EP1472344B1 (de) 2008-01-02
IL162917A0 (en) 2005-11-20
AU2003205993B2 (en) 2007-10-18
ATE382685T1 (de) 2008-01-15
US20050153415A1 (en) 2005-07-14
WO2003066845A2 (en) 2003-08-14
JP2005516618A (ja) 2005-06-09
JP4436135B2 (ja) 2010-03-24
WO2003066845A3 (en) 2003-12-24
CA2474145A1 (en) 2003-08-14
DE60318391T2 (de) 2009-01-02
ES2298495T3 (es) 2008-05-16
AU2003205993A1 (en) 2003-09-02
CN1813062A (zh) 2006-08-02
GB0202556D0 (en) 2002-03-20
US7371375B2 (en) 2008-05-13

Similar Documents

Publication Publication Date Title
DE60318391D1 (de) Bakteriophagen-lysin
ATE462006T1 (de) Isoform des vegfs
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
ATE541944T1 (de) Polynukleotidprimer
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
FI961202A (fi) Grb3-3-geeni, sen variantteja ja niiden käyttöjä
DE69934415D1 (de) Neuartiges collectin
SG146640A1 (en) Isolated photoprotein mtclytin, and use thereof
ATE435291T1 (de) Allele des glucokinasegens von coryneformen bakterien
DE50213015D1 (de) Lipase-varianten
ATE376586T1 (de) Ppgpp-synthetase und expressionssysteme zur verbesserten herstellung von proteinen
ATE412753T1 (de) Antibakterielles protein chlamysin-b, dafür kodierendes gen und ein expresionssystem dafür
ES2260624T3 (es) Deteccion de mutaciones.
AR112358A2 (es) Genes de toxinas y métodos de utilización de los mismos
PT1537210E (pt) Inibicao de oliconucleotidos decoy de expressao cd-40
DE60123787D1 (de) Neuartige, aliphatische acyltransferase-gene
TW200617021A (en) Isolated photoprotein aequorin y89f, and its use
ATE517181T1 (de) Rekombinante carboxypeptidase b

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIOMERIEUX S.A., MARCY L'ETOILE, FR

Owner name: HYGLOS INVEST GMBH, 82347 BERNRIED, DE

8328 Change in the person/name/address of the agent

Representative=s name: DEHMEL & BETTENHAUSEN PATENT- UND RECHTSANWAELTE,